Strybol Invest
0459.503.747 · rovalta.com · 24/09/2026
ACTIVE
Strybol Invest
Financial year 2023 · Closed on 31/12/2023
Net result
372,7 k €
+677,7 %over 1 yearGross margin
1,7 M €
+74,3 %over 1 yearEquity
1,7 M €
+27,5 %over 1 yearWorkforce
9,5 ETP
+6,7 %over 1 yearOverview
Identity
Source · BCE/KBOStrybol Invest is a Private limited company incorporated in 1996. Its main activity is: Activities of holding companies. Its registered office is in Maldegem. It employs on average 9,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0459.503.747
- Incorporation
- 19/12/1996
- Legal form
- Private limited company
- Registered office
- Donkstraat 120A
9990 Maldegem · FlandreSee on map - Contributed capital
- 692 000,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 9,5 ETP
Activities (NACE)
Joint committees (3)
- 100
- 218
- 313
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 19 filingsTrend over 16 financial years
| 2023 | 2022 | 2021 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,7 M € | +74.3% | 988,8 k € | -17.6% | 1,2 M € | +990% | 110,1 k € | -38.0% | 177,6 k € |
| EBITDA | 927,2 k € | +89.6% | 489 k € | -26.1% | 661,5 k € | +1160% | 52,5 k € | -58.5% | 126,6 k € |
| Operating result | 717 k € | +232% | 215,8 k € | -44.4% | 387,7 k € | +1602% | 22,8 k € | -76.0% | 95 k € |
| Net result | 372,7 k € | +678% | 47,9 k € | -77.5% | 212,6 k € | +548% | -47,4 k € | -224% | 38,3 k € |
| Balance sheet | |||||||||
| Equity | 1,7 M € | +27.5% | 1,4 M € | +3.7% | 1,3 M € | +10.0% | 1,2 M € | -3.8% | 1,2 M € |
| Total assets | 5,6 M € | -12.1% | 6,4 M € | -2.9% | 6,6 M € | +60.2% | 4,1 M € | +61.6% | 2,5 M € |
| Cash | 401,3 k € | +67.0% | 240,3 k € | -8.1% | 261,4 k € | -17.1% | 315,4 k € | +237% | 93,7 k € |
| Debts | 3,8 M € | -23.5% | 5 M € | -4.5% | 5,2 M € | +81.0% | 2,9 M € | +128% | 1,3 M € |
| Other | |||||||||
| Workforce | 9,5 ETP | +6.7% | 8,9 ETP | -16.0% | 10,6 ETP | +563% | 1,6 ETP | +14.3% | 1,4 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20232 active · 5 ended
Active mandates
Geert Strybol
ActiveMarie Anne Dobbelaere
ActiveEnded mandates
Geert Strybol
EndedGeert Strybol
EndedGeert Strybol
EndedMarie Anne Dobbelaere
EndedOther companies at this address
Donkstraat 120A 9990 Maldegem| Company | CBE no. |
|---|---|
Strybol Iben Pharma● Active | 0766.610.695 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/07/2025 | 28/08/2024 | 07/07/2023 | 20/07/2022 | 27/07/2021 | 30/07/2020 |
| General meeting | 04/06/2025 | 30/06/2024 | 07/06/2023 | 01/06/2022 | 02/06/2021 | 03/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 04/06/2025 | 23/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/06/2024 | 28/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 07/06/2023 | 07/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/06/2022 | 20/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 02/06/2021 | 27/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 03/06/2020 | 30/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 05/06/2019 | 04/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 06/06/2018 | 24/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 07/06/2017 | 25/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 15/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 03/06/2015 | 24/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 04/06/2014 | 25/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 10/10/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/08/2012 | 31/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 05/10/2011 | 28/10/2011 | Dutch | |
| Abridged model | 31/12/2009 | 02/06/2010 | 14/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 03/06/2009 | 14/10/2009 | Dutch | |
| Abridged model | 31/12/2007 | 04/06/2008 | 08/10/2008 | Dutch | |
| Abridged model | 31/12/2006 | 06/06/2007 | 04/12/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20232 active · 5 ended
Active mandates
Geert Strybol
ActiveMarie Anne Dobbelaere
ActiveEnded mandates
Geert Strybol
EndedGeert Strybol
EndedGeert Strybol
EndedMarie Anne Dobbelaere
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates02/04/2025ONTSLAGEN - BENOEMINGEN
- Restructuring25/09/2024BENAMING - DOEL - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring25/06/2024RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring14/08/2019BENAMING - DOEL - WIJZIGING RECHTSVORM - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring14/06/2019RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Other02/07/2014DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares06/02/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other06/01/2012STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023372,7 k €↑
- 2022Annual accounts 202247,9 k €↓
- 2021Annual accounts 2021212,6 k €↑
- 2019Name changeSTRYBOL PHARMA
- 2018Annual accounts 2018-47,4 k €↓
- 2017Annual accounts 201738,3 k €↑
- 2016Annual accounts 201632,3 k €↓
- 2015Annual accounts 201573,9 k €↓
- 2014Annual accounts 2014220 k €↑
- 2013Annual accounts 201353,9 k €↓
- 2012Annual accounts 201289,4 k €↑
- 2011Annual accounts 201159,9 k €↑
- 2010Annual accounts 20102 k €↓
- 2009Annual accounts 2009290,8 k €↑
- 2008Annual accounts 200834,2 k €↓
- 2007Annual accounts 200756,6 k €↓
- 2006Annual accounts 200667 k €
- 2006Name changeSTRYBOL-DOBBELAERE
- 19/12/1996IncorporationPrivate limited company